Lisata Therapeutics (LSTA) Short Interest Ratio & Short Volume $2.51 +0.01 (+0.40%) Closing price 05/22/2025 03:48 PM EasternExtended Trading$2.54 +0.03 (+1.00%) As of 07:46 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lisata Therapeutics Short Interest DataLisata Therapeutics (LSTA) has a short interest of 25,900 shares, representing 0.39% of the float (the number of shares available for trading by the public). This marks a -9.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 21,503 shares to cover all short positions.Current Short Interest25,900 sharesPrevious Short Interest28,500 sharesChange Vs. Previous Month-9.12%Dollar Volume Sold Short$61,383.00Short Interest Ratio1.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares8,616,000 sharesFloat Size6,720,000 sharesShort Percent of Float0.39%Today's Trading Volume18,442 sharesAverage Trading Volume21,503 sharesToday's Volume Vs. Average86% Short Selling Lisata Therapeutics? Sign up to receive the latest short interest report for Lisata Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLSTA Short Interest Over TimeLSTA Days to Cover Over TimeLSTA Percentage of Float Shorted Over Time Lisata Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202525,900 shares $61,383.00 -9.1%0.4%1.9 $2.37 4/15/202528,500 shares $61,845.00 -15.7%0.4%1.5 $2.17 3/31/202533,800 shares $79,430.00 +7.0%0.5%1 $2.35 3/15/202531,600 shares $75,524.00 -21.2%0.5%0.8 $2.39 2/28/202540,100 shares $95,438.00 +50.2%0.6%1 $2.38 2/15/202526,700 shares $67,017.00 +29.6%0.4%0.6 $2.51 1/31/202520,600 shares $51,500.00 -16.9%0.3%0.5 $2.50 1/15/202524,800 shares $92,256.00 +51.2%0.4%0.6 $3.72 12/31/202416,400 shares $48,872.00 -14.1%0.2%0.6 $2.98 12/15/202419,100 shares $49,278.00 +26.5%0.3%1.2 $2.58 Get the Latest News and Ratings for LSTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lisata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202415,100 shares $41,676.00 +59.0%0.2%1 $2.76 11/15/20249,500 shares $27,075.00 -44.4%0.1%0.7 $2.85 10/31/202417,100 shares $48,393.00 -28.2%0.3%1.4 $2.83 10/15/202423,800 shares $70,019.60 +91.9%0.4%2.3 $2.94 9/30/202412,400 shares $37,200.00 -10.8%0.2%1 $3.00 9/15/202413,900 shares $40,449.00 -38.0%0.2%1.1 $2.91 8/31/202422,400 shares $63,616.00 +202.7%0.3%1.5 $2.84 8/15/20247,400 shares $21,386.00 -24.5%0.1%0.5 $2.89 7/31/20249,800 shares $31,556.00 -13.3%0.1%0.6 $3.22 7/15/202411,300 shares $41,019.00 -22.1%0.2%0.7 $3.63 6/30/202414,500 shares $50,315.00 +10.7%0.2%0.9 $3.47 6/15/202413,100 shares $47,160.00 -45.9%0.2%0.9 $3.60 5/31/202424,200 shares $71,148.00 +118.0%0.4%1.6 $2.94 5/15/202411,100 shares $31,572.84 -25.0%0.2%0.8 $2.84 4/30/202414,800 shares $40,404.00 -8.1%0.2%1.2 $2.73 4/15/202416,100 shares $45,563.00 -4.2%0.2%1.2 $2.83 3/31/202416,800 shares $52,416.00 +69.7%0.3%1.2 $3.12 3/15/20249,900 shares $30,492.00 +28.6%0.2%0.7 $3.08 2/29/20247,700 shares $22,561.00 -33.0%0.1%0.6 $2.93 2/15/202411,500 shares $33,005.00 +8.5%0.2%0.8 $2.87 1/31/202410,600 shares $26,182.00 -83.0%0.2%0.7 $2.47 1/15/202462,400 shares $188,448.00 +4.5%1.0%3.7 $3.02 12/31/202359,700 shares $162,981.00 +497.0%0.9%3 $2.73 12/15/202310,000 shares $27,400.00 -82.1%0.2%0.5 $2.74 11/30/202355,800 shares $122,202.00 +17.5%0.8%2.8 $2.19 11/15/202347,500 shares $106,400.00 -13.0%0.7%2.2 $2.24 10/31/202354,600 shares $118,482.00 +10.5%0.8%2.6 $2.17 10/15/202349,400 shares $106,333.50 -11.6%0.7%1.5 $2.15 9/30/202355,900 shares $119,626.00 -23.8%0.8%1.9 $2.14 9/15/202373,400 shares $160,012.00 +17.6%1.1%2.5 $2.18Gold Hits New Highs as Global Markets Spiral (Ad)When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.Go Here to Learn What's Happening and How to Prepare >> 8/31/202362,400 shares $136,032.00 +16.4%0.9%2.1 $2.18 8/15/202353,600 shares $144,720.00 -2.9%0.8%2.2 $2.70 7/31/202355,200 shares $174,984.00 -12.0%0.8%1.9 $3.17 7/15/202362,700 shares $232,617.00 +3.8%1.0%3.8 $3.71 6/30/202360,400 shares $223,480.00 -11.3%0.9%3.8 $3.70 6/15/202368,100 shares $288,063.00 +4.0%1.0%4.4 $4.23 5/31/202365,500 shares $268,550.00 +22.4%1.0%4.8 $4.10 5/15/202353,500 shares $181,365.00 No Change0.8%3.8 $3.39 LSTA Short Interest - Frequently Asked Questions What is Lisata Therapeutics' current short interest? Short interest is the volume of Lisata Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 25,900 shares of LSTA short. 0.39% of Lisata Therapeutics' shares are currently sold short. Learn More on Lisata Therapeutics' current short interest. What is a good short interest ratio for Lisata Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LSTA shares currently have a short interest ratio of 2.0. Learn More on Lisata Therapeutics's short interest ratio. What is a good short interest percentage for Lisata Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.39% of Lisata Therapeutics' floating shares are currently sold short. Is Lisata Therapeutics' short interest increasing or decreasing? Lisata Therapeutics saw a decline in short interest in April. As of April 30th, there was short interest totaling 25,900 shares, a decline of 9.1% from the previous total of 28,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Lisata Therapeutics' float size? Lisata Therapeutics currently has issued a total of 8,616,000 shares. Some of Lisata Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lisata Therapeutics currently has a public float of 6,720,000 shares. How does Lisata Therapeutics' short interest compare to its competitors? 0.39% of Lisata Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Lisata Therapeutics: Inozyme Pharma, Inc. (9.12%), Caribou Biosciences, Inc. (9.42%), Adaptimmune Therapeutics plc (1.70%), Genenta Science S.p.A. (0.02%), Exicure, Inc. (1.15%), CytomX Therapeutics, Inc. (12.08%), Telomir Pharmaceuticals, Inc. (12.93%), ESSA Pharma Inc. (1.60%), Sutro Biopharma, Inc. (6.32%), Pyxis Oncology, Inc. (16.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Lisata Therapeutics stock? Short selling LSTA is an investing strategy that aims to generate trading profit from Lisata Therapeutics as its price is falling. LSTA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lisata Therapeutics? A short squeeze for Lisata Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LSTA, which in turn drives the price of the stock up even further. How often is Lisata Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LSTA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Inozyme Pharma Short Squeeze Caribou Biosciences Short Squeeze Adaptimmune Therapeutics Short Squeeze Genenta Science Short Squeeze Exicure Short Squeeze CytomX Therapeutics Short Squeeze Telomir Pharmaceuticals Short Squeeze ESSA Pharma Short Squeeze Sutro Biopharma Short Squeeze Pyxis Oncology Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LSTA) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lisata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.